Literature DB >> 10200344

Detection of DNA polymorphisms and point mutations of high-affinity nerve growth factor receptor (TrkA) in human neuroblastoma.

P Scaruffi1, R Cusano, M Dagnino, G P Tonini.   

Abstract

We have studied nerve growth factor (NGF) receptors in 63 neuroblastoma tissues. We found DNA polymorphisms of TrkA consisting in C-->T transitions in tyrosine kinase domain at 6773, 7232 and 7301 nucleotides. Both C/T alleles were detected in tumors belonging to patients at stages 1, 2, 3 and 4 but not in 4S that expresses only the allele with C-->T. Furthermore, we detected a GT transversion resulting in a Gly-->Val substitution in a stage 4 and a stage 4S samples. We report the first evidence of TrkA polymorphism and point mutations in neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10200344     DOI: 10.3892/ijo.14.5.935

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Clinical significance of NTRK family gene expression in neuroblastomas.

Authors:  Jennifer E Light; Hiroshi Koyama; Jane E Minturn; Ruth Ho; Anisha M Simpson; Radhika Iyer; Jennifer L Mangino; Venkatadri Kolla; Wendy B London; Garrett M Brodeur
Journal:  Pediatr Blood Cancer       Date:  2011-10-11       Impact factor: 3.167

Review 2.  Trk receptor expression and inhibition in neuroblastomas.

Authors:  Garrett M Brodeur; Jane E Minturn; Ruth Ho; Anisha M Simpson; Radhika Iyer; Carly R Varela; Jennifer E Light; Venkatadri Kolla; Audrey E Evans
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

Review 3.  Neuroblastoma treatment in the post-genomic era.

Authors:  Maria Rosaria Esposito; Sanja Aveic; Anke Seydel; Gian Paolo Tonini
Journal:  J Biomed Sci       Date:  2017-02-08       Impact factor: 8.410

4.  EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.

Authors:  Zhenghao Li; Hisanori Takenobu; Amallia Nuggetsiana Setyawati; Nobuhiro Akita; Masayuki Haruta; Shunpei Satoh; Yoshitaka Shinno; Koji Chikaraishi; Kyosuke Mukae; Jesmin Akter; Ryuichi P Sugino; Atsuko Nakazawa; Akira Nakagawara; Hiroyuki Aburatani; Miki Ohira; Takehiko Kamijo
Journal:  Oncogene       Date:  2018-03-06       Impact factor: 9.867

5.  c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients.

Authors:  Beata S Lipska; Elzbieta Drozynska; Paola Scaruffi; Gian Paolo Tonini; Ewa Izycka-Swieszewska; Szymon Zietkiewicz; Anna Balcerska; Danuta Perek; Alicja Chybicka; Wojciech Biernat; Janusz Limon
Journal:  BMC Cancer       Date:  2009-12-13       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.